Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5-year survival of approximately 20%. The disease primarily occurs in elderly patients. IPF is a highly heterogeneous disorder with a clinical course that varies from prolonged periods of stability to episodes of rapid deteriorati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreuter, Michael, Bonella, Francesco, Wijsenbeek, Marlies, Maher, Toby M., Spagnolo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686637/
https://www.ncbi.nlm.nih.gov/pubmed/26779535
http://dx.doi.org/10.1155/2015/329481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686637/
https://www.ncbi.nlm.nih.gov/pubmed/26779535
http://dx.doi.org/10.1155/2015/329481

Ejemplares similares